Effect of rotavirus vaccine implementation on the prevalence of coinfections with enteric viruses in Norway

J Med Virol. 2020 Dec;92(12):3151-3156. doi: 10.1002/jmv.26013. Epub 2020 Jul 28.

Abstract

Acute gastroenteritis (AGE) is a common illness in both adults and children worldwide and is caused by several microorganisms including viruses, bacteria, and parasites. Rotavirus (RV), which is the main cause of AGE, can occur as a mixed infection with other viruses. The aim of this study is to assess the molecular epidemiology of viral enteric viruses and assess RV coinfections with other enteric viruses and their influence on disease severity before and after RV vaccine introduction in children under 5 years of age. A total of 600 samples collected from children hospitalized for AGE in five large hospitals in Norway, and were analyzed for viral gastroenteritis agents by enzyme immunoassay and quantitative real-time polymerase chain reaction (qRT-PCR). Positive results confirmed either by Sanger sequencing or genotyped by multiplex semi-nested RT-PCR. In total, 243 of the 300 (81%) samples, collected from the prevaccine cohort, were positive for at least one of the four viruses tested in this study. RV was most frequently identified in 82.6% of the samples. In the postvaccine cohort, 114 of the 300 (38%) samples were positive for at least one of the viruses tested. RV found in 36.5% of the samples. Coinfections found less frequently in the postvaccine cohort. Among circulating enteric viruses in Norway, RV is the most important cause of viral gastrointestinal infection. As expected, there were fewer RV positive and fewer coinfections after RV vaccine implementation. The results provide valuable data that can aid in further evaluation of the vaccine impact.

Keywords: AGE; coinfections; norovirus; qRT-PCR; rotavirus; vaccine shedding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Coinfection* / epidemiology
  • Coinfection* / virology
  • Enterovirus / classification
  • Enterovirus / genetics
  • Enterovirus / immunology
  • Enterovirus / isolation & purification
  • Enterovirus Infections / epidemiology
  • Enterovirus Infections / prevention & control
  • Enterovirus Infections / virology
  • Feces / virology
  • Female
  • Gastroenteritis* / epidemiology
  • Gastroenteritis* / prevention & control
  • Gastroenteritis* / virology
  • Genotype
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Molecular Epidemiology
  • Norway / epidemiology
  • Prevalence
  • Real-Time Polymerase Chain Reaction
  • Rotavirus / genetics
  • Rotavirus / immunology
  • Rotavirus / isolation & purification
  • Rotavirus Infections / epidemiology
  • Rotavirus Infections / prevention & control
  • Rotavirus Infections / virology
  • Rotavirus Vaccines* / administration & dosage
  • Rotavirus Vaccines* / immunology

Substances

  • Rotavirus Vaccines